tetradecanoylphorbol acetate and dehydroglyasperin c

tetradecanoylphorbol acetate has been researched along with dehydroglyasperin c in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heo, YS; Jang, YJ; Jung, SK; Kim, JE; Kim, JR; Lee, CC; Lee, CY; Lee, E; Lee, HJ; Lee, JH; Lee, KW; Lim, SS; Lim, TG; Seo, SG; Son, JE	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and dehydroglyasperin c

Article	Year
Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K. Molecular carcinogenesis, 2016, Volume: 55, Issue:5 Topics: Animals; Benzopyrans; Carcinogens; Cell Line; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Cyclooxygenase 2; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase 4; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Binding; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1	2016

Article

Year

Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K.

Molecular carcinogenesis, 2016, Volume: 55, Issue:5

Topics: Animals; Benzopyrans; Carcinogens; Cell Line; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Cyclooxygenase 2; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase 4; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Binding; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

2016